EE195 Economic Burden of Patients with Gastroesophageal Reflux Disease in Chinese

X. Yu,X. Hou,Y. Sheng,L. Xie
DOI: https://doi.org/10.1016/j.jval.2022.04.444
IF: 5.156
2022-01-01
Value in Health
Abstract:Gastroesophageal reflux disease (GERD) has a prevalence of 4.2% in China, causing troublesome symptoms and economic strain with direct and indirect costs that adversely impact patients’ quality of life. This real-world study aimed to assess the economic burden of GERD patients in China by collecting data on cost and utilization of medical resources.
What problem does this paper attempt to address?